Dual crisis: environmental and economic unsustainability in NHS dry eye prescribing

Read full text
Authors: Jack Ao, Saaeha Rauz, Anat Galor, Stephen B. Kaye
Cited by: 1
References: 15

Abstract

Dry eye disease (DED) is a multifactorial condition affecting up to 14.4% of all adults, with symptoms ranging from ocular discomfort to visual disturbances. 1 Despite its complexity, treatment frequently defaults to the use of lubricating drops, commonly referred to as artificial tears, without addressing the many underlying associations and causes. Some of these may be preventable or modifiable, including vitamin D deficiency,2 dyslipidaemia,3 4 environmental triggers5 and medication side effects, while others, such as autoimmune diseases, necessitate alternative forms of treatment.6 The variable cytotoxicity of the essential components of lubricating drops is often not realised, which may lead to a cycle of damage and more intensive lubricating drop usage.7–9

Fields of Study & Subjects

Ocular Surface and Contact Lens Ocular Infections and Treatments Urticaria and Related Conditions

Publication details

Journal / source
BMJ Open Ophthalmology
Publisher
BMJ
Volume
11
Issue
1
Pages
e002701–e002701
Publication date
1 January 2026
Language
EN